3-45485607-C-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_015340.4(LARS2):​c.1019-85C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.961 in 730,388 control chromosomes in the GnomAD database, including 341,504 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.89 ( 61946 hom., cov: 32)
Exomes 𝑓: 0.98 ( 279558 hom. )

Consequence

LARS2
NM_015340.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.324

Publications

3 publications found
Variant links:
Genes affected
LARS2 (HGNC:17095): (leucyl-tRNA synthetase 2, mitochondrial) This gene encodes a class 1 aminoacyl-tRNA synthetase, mitochondrial leucyl-tRNA synthetase. Each of the twenty aminoacyl-tRNA synthetases catalyzes the aminoacylation of a specific tRNA or tRNA isoaccepting family with the cognate amino acid. [provided by RefSeq, Jul 2008]
LARS2-AS1 (HGNC:40796): (LARS2 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BP6
Variant 3-45485607-C-G is Benign according to our data. Variant chr3-45485607-C-G is described in ClinVar as Benign. ClinVar VariationId is 676142.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.991 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_015340.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LARS2
NM_015340.4
MANE Select
c.1019-85C>G
intron
N/ANP_056155.1Q15031
LARS2
NM_001368263.1
c.1019-85C>G
intron
N/ANP_001355192.1Q15031
LARS2-AS1
NR_048543.1
n.518-1576G>C
intron
N/A

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LARS2
ENST00000645846.2
MANE Select
c.1019-85C>G
intron
N/AENSP00000495093.1Q15031
LARS2
ENST00000265537.8
TSL:1
n.1019-85C>G
intron
N/AENSP00000265537.4A0A499FJL2
LARS2
ENST00000935381.1
c.1019-85C>G
intron
N/AENSP00000605440.1

Frequencies

GnomAD3 genomes
AF:
0.886
AC:
134756
AN:
152118
Hom.:
61907
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.611
Gnomad AMI
AF:
1.00
Gnomad AMR
AF:
0.953
Gnomad ASJ
AF:
0.997
Gnomad EAS
AF:
1.00
Gnomad SAS
AF:
0.958
Gnomad FIN
AF:
1.00
Gnomad MID
AF:
0.972
Gnomad NFE
AF:
0.998
Gnomad OTH
AF:
0.910
GnomAD4 exome
AF:
0.981
AC:
567068
AN:
578152
Hom.:
279558
AF XY:
0.982
AC XY:
298237
AN XY:
303758
show subpopulations
African (AFR)
AF:
0.588
AC:
9633
AN:
16376
American (AMR)
AF:
0.970
AC:
22179
AN:
22864
Ashkenazi Jewish (ASJ)
AF:
0.995
AC:
14289
AN:
14360
East Asian (EAS)
AF:
1.00
AC:
32556
AN:
32564
South Asian (SAS)
AF:
0.962
AC:
41666
AN:
43322
European-Finnish (FIN)
AF:
1.00
AC:
46347
AN:
46348
Middle Eastern (MID)
AF:
0.971
AC:
3606
AN:
3712
European-Non Finnish (NFE)
AF:
0.998
AC:
368486
AN:
369270
Other (OTH)
AF:
0.965
AC:
28306
AN:
29336
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
371
742
1114
1485
1856
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3852
7704
11556
15408
19260
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.886
AC:
134853
AN:
152236
Hom.:
61946
Cov.:
32
AF XY:
0.889
AC XY:
66216
AN XY:
74452
show subpopulations
African (AFR)
AF:
0.612
AC:
25359
AN:
41456
American (AMR)
AF:
0.953
AC:
14581
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.997
AC:
3461
AN:
3472
East Asian (EAS)
AF:
1.00
AC:
5190
AN:
5190
South Asian (SAS)
AF:
0.958
AC:
4626
AN:
4828
European-Finnish (FIN)
AF:
1.00
AC:
10630
AN:
10630
Middle Eastern (MID)
AF:
0.973
AC:
286
AN:
294
European-Non Finnish (NFE)
AF:
0.998
AC:
67880
AN:
68040
Other (OTH)
AF:
0.911
AC:
1928
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
567
1135
1702
2270
2837
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
878
1756
2634
3512
4390
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.932
Hom.:
7949
Bravo
AF:
0.868
Asia WGS
AF:
0.960
AC:
3338
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.78
CADD
Benign
1.4
DANN
Benign
0.74
PhyloP100
-0.32
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7640603; hg19: chr3-45527099; API